相关实验视频
Updated: Jul 20, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.9K
在婴儿≥35周预计妊娠年龄使用标准化协议的婴儿高 bilirubinemia 的再入院减少
Joint Commission journal on quality and patient safety
|August 20, 2023
概括
实施新的协议显著减少了66%的新生儿再接收,这是由于高白血症. 这项质量改善计划平衡了治疗风险,改善了婴儿护理结果.
科学领域:
- 新生儿护理 新生儿护理
- 改善儿科的质量改善.
- 公共卫生 公共卫生
背景情况:
- 新生儿高 bilirubinemia 是常见的,但再接收带来风险.
- 超白血症占研究医院所有再入院病例的91%.
- 目标是在8个月内将高白血症再入院率降低60%.
研究的目的:
- 为了降低新生儿高 bilirubinemia 的再接收率.
- 实施和评估婴儿黄管理的质量改进方案.
主要方法:
- 精益系统方法用于根源原因分析和干预.
- 开发了一种特定的超白血病方案,并升级了光疗设备.
- 统计过程控制图表监测了每月的再接收率和其他关键指标.
主要成果:
- 超白血症的每月再入院率从1.9%的基线下降到0.64%.
- 这意味着再接收人数减少了66%,超过了项目的目标.
- 没有观察到实验室利用率,光疗开始或住院时间的显著变化.
结论:
- 实施的协议有效地减少了超白血病的再入院,而不会对其他护理指标产生不良影响.
- 该协议为类似的医疗保健设施,特别是军事治疗中心提供了潜在的模型.
- 质量改善举措对于优化新生儿护理和减少可预防的再入院至关重要.
相关概念视频
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...

